A 61 year old man presented to the emergency department with sudden onset breathlessness associated with cough productive of purulent sputum. He had been diagnosed with squamous cell carcinoma of the bronchus one month earlier. His staging was T4N2M1. Two weeks earlier he had developed a pathological clavicular fracture and was due to start radiotherapy. On admission he had no haemoptysis or chest pain. However, his blood pressure was 80/40 mm Hg, pulse rate was 140-160 beats/min, and respiratory rate was 18 breaths/min.
On examination he had swelling and plethora of the face and neck. Crepitations were heard in the right mid zone of his lung field. Heart sounds were normal. His jugular venous pressure was non-pulsatile and was raised to the level of his ear lobes. His breathlessness and facial swelling were exacerbated by lying flat and coughing.
Electrocardiography showed sinus tachycardia. Arterial blood gas on room air showed a partial pressure of oxygen of 7 kPa, and a partial pressure of carbon dioxide of 4.2 kPa.
Chest radiography was performed (fig 1) .
Fig 1 Chest radiograph on admission
An echocardiogram showed no pericardial effusion but moderate left ventricular function and no right ventricular dysfunction. Figure 2 is a picture of the patient at admission. 
Answers 1 What is the most likely diagnosis? Short answer
Obstruction of the superior vena cava.
Long answer
This patient has obstruction of the superior vena cava. His chest is plethoric, and on closer inspection he has some distended thoracic veins (fig 3) . His chest radiograph on admission shows a widened mediastinum and a right hilar mass, which, given his background, is probably bronchial carcinoma (fig 4) . Computed tomographic pulmonary angiography ( fig 5) shows extrinsic compression of the superior vena cava by this lesion and the development of collateral vessels in the chest wall. Mild bilateral pleural effusions are also present; this is a common finding in patients with superior vena cava obstruction, affecting about two thirds of this population. In addition, right lower lobe consolidation and air bronchograms are seen, suggestive of pneumonia. Chest computed tomography often detects pneumonia that cannot clearly be seen using chest radiography (fig 4) . The pneumonia was not detected on chest radiography until two weeks later, when it was at an advanced stage ( fig 6) . The superior vena cava is the drainage vessel for blood returning from the head, neck, upper thorax, and arms. It is prone to obstruction because of its thin wall, low pressure, and rigid neighbouring structures, such as the right main bronchus. Low intravascular pressure also allows thrombus formation. Superior vena cava obstruction can be acute or subacute, but it commonly develops over the course of weeks. This allows the formation of collateral blood flow and leads to distension of the thoracic veins.
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Patients may develop plethora and oedema of the face, upper arms, and chest ( fig 3) ; dyspnoea; and a raised jugular venous pressure with absent pulsation. These symptoms are exacerbated by manoeuvres that further increase venous pressure, such as coughing, sneezing, bending forwards, or lying down flat.
Superior vena cava obstruction may cause death through airway obstruction from laryngeal or bronchial oedema, which manifests as stridor. Another life threatening consequence is cerebral oedema, which can cause headaches, confusion, and coma. 1 2 In our patient the major differential diagnosis was a pulmonary embolism in view of the sudden breathlessness, hypotension, sinus tachycardia, and hypoxaemia. A bedside echocardiogram showed no right heart dysfunction, although computed tomography pulmonary angiography did show a clot in the left subclavian vein.
What are the likely causes of this condition? Short answer
More than 90% of cases of superior vena cava obstruction are caused by cancer. Non-malignant causes include intravascular devices, aortic aneurysms, and fibrosing mediastinitis.
Long answer
Superior vena cava obstruction may be caused by extravascular compression, direct neoplastic invasion, or intravascular obstruction.
Extravascular compression of the superior vena cava is typically caused by cancer arising from the right upper lobe or main bronchus, or enlarged mediastinal lymphadenopathy. Neoplastic growth may also invade the superior vena cava and become a focal point for thrombus formation. 4 Cancer accounts for more than 90% of cases of superior vena cava obstruction.
1 2 5 The most common cancers are non-small cell lung cancer, small cell lung cancer, non-Hodgkin's lymphoma, and metastatic deposits. Thymomas and germ cell tumours are rarer causes. The prognosis for both types of lung cancer is poor, with a two year survival of about 5% for each. 6 Other benign causes include aortic aneurysms and fibrosing mediastinitis. 7 In addition, infectious causes, such as klebsiella of the right upper lobe, 8 nocardia, 9 mycobacteria, 10 and amoebiasis, 11 have been reported.
Intravascular obstruction is becoming more common with the increasing use of intravascular devices, such as long term central venous catheters or pacemaker electrodes, which can cause thrombosis.
In this case, superior vena cava obstruction was caused by extravascular compression by tumour and intravascular obstruction by thrombosis.
What further investigation would you do? Short answer
Computed tomography pulmonary angiography.
Long answer
Several modes of imaging are available. In this case, computed tomography pulmonary angiography was ordered out of hours to investigate possible superior vena cava obstruction and pulmonary embolus. This test is commonly available out of hours and can often detect the cause of the obstruction with high sensitivity and specificity. Computed tomography pulmonary angiography with a wide window setting or contrast enhanced multidetector row computed tomography is the preferred investigation for the evaluation of pulmonary embolism and superior vena cava obstruction.
Contrast enhanced multidetector row computed tomography can locate the site of occlusion or stenosis in superior vena cava obstruction and can detect the presence of an intravascular thrombus with high sensitivity and specificity. With the addition of multiplanar and three dimensional reconstructions, its advantage over conventional computed tomography angiography is its superior quality image resolution, faster imaging time, and increased anatomical coverage; it is also less expensive and is associated with a lower radiation dose.
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Magnetic resonance imaging can be used if contrast is contraindicated. However, this test has a longer imaging time, more problems with patient compliance, and is more expensive.
1 13 14 Venography is considered the gold standard to confirm stenosis or occlusion as a result of superior vena cava obstruction. It can also detect and delineate the extent of any thrombus formation and provides useful information on vessel anatomy. However, it is an invasive procedure and usually considered when a therapeutic intervention such as stenting is planned.
How would you manage this patient? Short answer
Raise the patient's head and give high dose dexamethasone. Radiotherapy and chemotherapy are used in malignant obstructions but take two to four weeks to have an effect. Placement of an endovascular stent relieves symptoms within 72 hours.
Long answer
Management depends on the cause. Cases of malignancy require treatment of the cancer as well as symptomatic relief from the obstruction, so multidisciplinary team involvement is essential.
Obstruction of the superior vena cava used to be considered a medical emergency. This is now known not to be the case for most patients, because outcome is unrelated to symptom duration. However, it becomes an emergency if patients develop dyspnoea and stridor (as a result of bronchial or laryngeal oedema) or decreased consciousness (as a result of cerebral oedema), so vigilance is required. 15 Classification and grading systems for diagnosing the severity of superior vena cava obstruction have been proposed but not yet routinely adopted. They are based on clinical criteria because the severity of symptoms mostly determines the urgency of intervention.
In one proposed grading system, mild symptoms comprise head or neck oedema, cyanosis, and plethora; moderate symptoms include head or neck oedema with functional impairment (for example, dysphagia, cough, impaired movement of head); severe symptoms encompass mild or moderate cerebral oedema, laryngeal oedema, and reduced cardiac reserve (for example, syncope after bending); life threatening symptoms include cerebral oedema causing confusion and obtundation, laryngeal oedema causing stridor, and haemodynamic compromise. 16 17 The first step in managing superior vena cava obstruction is to raise the patient's head to reduce oedema by reducing hydrostatic pressure. High dose dexamethasone, typically 4 mg four times daily, is often used. Corticosteroids work mainly by reducing tumour and airway oedema. Their benefits have been documented only in case studies, however, and their effectiveness remains uncertain.
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Diuretics were typically used in the symptomatic management of superior vena cava obstruction in the past. They were thought to work by reducing venous return to the heart, thereby decreasing pressure in the superior vena cava. However, reports of a beneficial effect remain only anecdotal.
Radiotherapy and chemotherapy are used traditionally in patients with malignant obstruction, and treatment depends on the stage, grade, and type of cancer. It can take two to four weeks to take effect and is associated with high rates of complications and relapse. 18 Systemic chemotherapy can lead to rapid relief of symptoms in patients with non-Hodgkin's lymphoma, small cell lung cancer, and germ cell tumours. Patients with a thymoma should have chemotherapy followed by surgical resection. It is important that stenting is avoided in these patients because it complicates resection.
About 60% of patients with non-small cell lung cancer experience a clinical response when treated with chemotherapy, radiotherapy, or chemoradiotherapy, but side effects are common. Relapse occurs in a third of patients treated with chemotherapy or radiotherapy. 19 Surgical treatment of superior vena cava obstruction involves bypass grafting using an autologous vein graft or a synthetic tube. Good patency results can be achieved but postoperative morbidity is high. Such an invasive treatment, which requires a sternotomy, may not be appropriate in patients with a poor life expectancy, especially when stenting is a practical alternative.
Stenting is indicated if life threatening symptoms are present because it provides the most immediate relief of symptoms. It should also be considered in patients with advanced cancer when effective treatment options are limited (for example, those with mesothelioma or in the palliative stage of cancer).
Our patient was thought to have a poor life expectancy. We thought that he was likely to deteriorate further in the time needed to respond to radiotherapy or chemotherapy (up to three months). Hence an endovascular stent was inserted to provide rapid relief of symptoms.
Systematic reviews have shown that endovascular stents are more effective than chemotherapy or radiotherapy in symptom relief. After placement of the expandable metal stent, symptomatic improvement is usually seen within 24-72 hours. A Cochrane review of studies on the treatment of superior vena cava obstruction in patients with lung cancer has shown that superior vena cava stents provide symptomatic relief in 95% of patients. Although recurrence occurred in 11% of these patients during eight months of follow-up, long term patency was restored in 92% after repeated intervention. In comparison, chemotherapy or radiotherapy (or both) caused relief in 77% of patients. The median life expectancy in patients treated with stenting ranged from 1.5 to 6.5 months. 19 Because these stents are thrombogenic in the first four weeks, patients are sometimes given anticoagulants for this period after the procedure, although the need and effectiveness of anticoagulation is unclear.
1 18 20 21 22 23 Other complications associated with stents are rare but include stent migration, 20 acute cardiogenic pulmonary oedema, 24 and cardiac tamponade. 25 Migration of the stent to the heart can lead to death. Therefore, after stent insertion, chest radiography to determine the position of the stent and Doppler ultrasound of the upper extremities to determine baseline venous waveforms are required before discharge.
Thrombolytics may be needed to dissolve the thrombus before stent placement in patients with extensive intravascular thrombosis; otherwise, there is a risk of thrombus migration and pulmonary embolism. More recently, catheter directed thrombolysis has been used, followed immediately by thrombus aspiration to remove the remaining pieces of clot, before insertion of the stent. The administration of thrombolytics is associated with increased morbidity, however, mostly from haemorrhage. It has been suggested that a longer follow-up of patients is needed to further evaluate the efficacy of this intervention. 26 27 The concurrent pneumonia was treated with intravenous piperacillin with tazobactam (Tazocin).
Patient outcome
This patient had an endovascular stent inserted, which provided symptomatic relief within 24 hours, and he was given anticoagulants after the procedure. His plethora and oedema were noticeably reduced by day 10, and he was later discharged home with palliative care input.
